SABR slows prostate cancer progression
March 27, 2020 -- A form of highly focused, intense radiation therapy called stereotactic ablative radiation (SABR) appears to slow the progression of metastatic prostate cancer in men with hormone-sensitive disease, according to a study published online March 26 in JAMA Oncology.
Discuss
March 27, 2020 -- A form of highly focused, intense radiation therapy called stereotactic ablative radiation (SABR) appears to slow the progression of metastatic prostate cancer in men with hormone-sensitive disease, according to a study published online March 26 in JAMA Oncology.
Discuss Telehealth rules relaxed for radiologists during COVID-19
March 24, 2020 -- In response to the COVID-19 outbreak, Medicare has temporarily opened up the ability for physicians to provide medical care to patients without the need for them to be in the same physical location. Sandy Coffta of Healthcare Administrative Partners explains whether this represents a new opportunity for radiologists.
Discuss
March 24, 2020 -- In response to the COVID-19 outbreak, Medicare has temporarily opened up the ability for physicians to provide medical care to patients without the need for them to be in the same physical location. Sandy Coffta of Healthcare Administrative Partners explains whether this represents a new opportunity for radiologists.
Discuss ASCO switches to online format for annual meeting
March 24, 2020 -- The American Society of Clinical Oncology (ASCO) will be converting its 2020 annual meeting to a virtual format due to the COVID-19 outbreak.
March 24, 2020 -- The American Society of Clinical Oncology (ASCO) will be converting its 2020 annual meeting to a virtual format due to the COVID-19 outbreak.
RefleXion gets FDA nod for rad therapy
March 13, 2020 -- Radiation therapy equipment developer RefleXion Medical has received U.S. Food and Drug Administration (FDA) clearance to market its flagship RefleXion X1 system for conventional radiation therapy treatments.
March 13, 2020 -- Radiation therapy equipment developer RefleXion Medical has received U.S. Food and Drug Administration (FDA) clearance to market its flagship RefleXion X1 system for conventional radiation therapy treatments.
Cancer deaths decline in the U.S.
March 13, 2020 -- The cancer death rate has continued to decline in the U.S., according to a report published on March 12 in the journal Cancer.
March 13, 2020 -- The cancer death rate has continued to decline in the U.S., according to a report published on March 12 in the journal Cancer.
ViewRay's revenue spikes in 2019, despite slow Q4
March 13, 2020 -- Image-guided radiation therapy vendor ViewRay is reporting growth in revenue of about 8% for its fiscal 2019. Orders also fell 50% in its fourth quarter.
March 13, 2020 -- Image-guided radiation therapy vendor ViewRay is reporting growth in revenue of about 8% for its fiscal 2019. Orders also fell 50% in its fourth quarter.
Framatome, Kinectrics partner on Lu-177
March 5, 2020 -- French nuclear reactor firm Framatome and Toronto-based Kinectrics have launched a joint venture, called Isogen, to provide support for the production of the medical isotope lutetium-177 (Lu-177).
March 5, 2020 -- French nuclear reactor firm Framatome and Toronto-based Kinectrics have launched a joint venture, called Isogen, to provide support for the production of the medical isotope lutetium-177 (Lu-177).
Korean researchers create isotope for cancer
March 4, 2020 -- The Korea Atomic Energy Research Institute has developed the technology to produce the medical isotope copper-67 for simultaneous cancer diagnosis and treatment, according to a March 4 report in the Korean Times.
March 4, 2020 -- The Korea Atomic Energy Research Institute has developed the technology to produce the medical isotope copper-67 for simultaneous cancer diagnosis and treatment, according to a March 4 report in the Korean Times.
RT + immunotherapy = head/neck cancer treatment option
February 28, 2020 -- A combination of radiation therapy and immunotherapy shows promise for patients with recurring or metastatic head and neck squamous cell carcinoma, according to a presentation delivered on February 28 at the Multidisciplinary Head and Neck Cancers Symposium in Scottsdale, AZ.
Discuss
February 28, 2020 -- A combination of radiation therapy and immunotherapy shows promise for patients with recurring or metastatic head and neck squamous cell carcinoma, according to a presentation delivered on February 28 at the Multidisciplinary Head and Neck Cancers Symposium in Scottsdale, AZ.
Discuss Isotopia, Eckert & Ziegler partner
February 18, 2020 -- Isotopia Molecular Imaging has partnered with isotope technology firm Eckert & Ziegler for the development of its PSMA-11 kit for prostate cancer imaging.
February 18, 2020 -- Isotopia Molecular Imaging has partnered with isotope technology firm Eckert & Ziegler for the development of its PSMA-11 kit for prostate cancer imaging.
Special Feature
IMV: Imaging boosts precision in radiation therapy
Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more
VENDOR CONNECT